hydroxychloroquine has been researched along with Hypertension, Pulmonary in 6 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Two years prior to admission to our hospital, she had been diagnosed with rheumatoid arthritis and treated with hydroxychloroquine (HCQ) with a cumulative dose of 164 g." | 7.78 | Hydroxychloroquine-induced cardiomyopathy that presented as pulmonary hypertension: a newly noted complication. ( Bae, SM; Chin, JY; Ihm, SM; Jung, HO; Kim, JJ; Kim, TS; Lee, KY; Park, SH; Youn, HJ, 2012) |
| " For inflammatory arthritis, 79% of experts agreed (first- through fourth-line treatments were MTX, low-dose glucocorticoids, hydroxychloroquine, and rituximab or tocilizumab, respectively)." | 3.88 | Treatment Algorithms for Systemic Sclerosis According to Experts. ( Fernández-Codina, A; Pope, JE; Walker, KM, 2018) |
| " Two years prior to admission to our hospital, she had been diagnosed with rheumatoid arthritis and treated with hydroxychloroquine (HCQ) with a cumulative dose of 164 g." | 3.78 | Hydroxychloroquine-induced cardiomyopathy that presented as pulmonary hypertension: a newly noted complication. ( Bae, SM; Chin, JY; Ihm, SM; Jung, HO; Kim, JJ; Kim, TS; Lee, KY; Park, SH; Youn, HJ, 2012) |
| "A rare case of childhood pulmonary haemosiderosis with juvenile idiopathic arthritis is discussed, with particular reference to treatment with hydroxychloroquine and sildenafil for pulmonary hypertension which occurs secondary to this disease." | 3.74 | Pulmonary haemosiderosis with juvenile idiopathic arthritis in a Malaysian child. ( Noor, AS; Quah, BS; Rasool, AH; Roberton, D; Wong, AR, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fanouriakis, A | 1 |
| Tziolos, N | 1 |
| Bertsias, G | 1 |
| Boumpas, DT | 1 |
| Kaur, H | 1 |
| Sarma, P | 1 |
| Bhattacharyya, A | 1 |
| Prajapat, M | 1 |
| Kumar, S | 1 |
| Prakash, A | 1 |
| Medhi, B | 1 |
| Fernández-Codina, A | 1 |
| Walker, KM | 1 |
| Pope, JE | 1 |
| Lochouarn, M | 1 |
| Lagier, JC | 1 |
| Raoult, D | 1 |
| Pulcini, C | 1 |
| Wong, AR | 1 |
| Noor, AS | 1 |
| Rasool, AH | 1 |
| Quah, BS | 1 |
| Roberton, D | 1 |
| Bae, SM | 1 |
| Jung, HO | 1 |
| Ihm, SM | 1 |
| Kim, JJ | 1 |
| Chin, JY | 1 |
| Kim, TS | 1 |
| Park, SH | 1 |
| Youn, HJ | 1 |
| Lee, KY | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Optimization of Glucocorticoid Taper Strategies for Maintenance Therapy of Systemic Lupus Erythematosus Associated Immune Thrombocytopenia (SLE-ITP)[NCT05506033] | 120 participants (Anticipated) | Interventional | 2022-08-15 | Enrolling by invitation | |||
| The Effectiveness of ECP in Diffuse Cutaneous Systemic Sclerosis[NCT04986605] | Phase 2 | 15 participants (Anticipated) | Interventional | 2023-12-01 | Not yet recruiting | ||
| Pragmatic Clinical Trials in Scleroderma[NCT03610217] | 400 participants (Anticipated) | Interventional | 2018-10-31 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for hydroxychloroquine and Hypertension, Pulmonary
| Article | Year |
|---|---|
Update οn the diagnosis and management of systemic lupus erythematosus.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Humanized; Autoantibodies; Azathioprine; Calc | 2021 |
5 other studies available for hydroxychloroquine and Hypertension, Pulmonary
| Article | Year |
|---|---|
Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
Topics: Angiotensin-Converting Enzyme 2; COVID-19; COVID-19 Drug Treatment; Folic Acid; Humans; Hydroxychlor | 2021 |
Treatment Algorithms for Systemic Sclerosis According to Experts.
Topics: Algorithms; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibodies, | 2018 |
Treatment Algorithms for Systemic Sclerosis According to Experts.
Topics: Algorithms; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibodies, | 2018 |
Treatment Algorithms for Systemic Sclerosis According to Experts.
Topics: Algorithms; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibodies, | 2018 |
Treatment Algorithms for Systemic Sclerosis According to Experts.
Topics: Algorithms; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antibodies, | 2018 |
A case of Whipple's disease evolving over 30 years.
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Aortic Valve Insufficiency; Biopsy; Disease Progressio | 2014 |
Pulmonary haemosiderosis with juvenile idiopathic arthritis in a Malaysian child.
Topics: Adolescent; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Juvenile; Female; Hemosideros | 2007 |
Hydroxychloroquine-induced cardiomyopathy that presented as pulmonary hypertension: a newly noted complication.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cardiac Catheterization; Cardiomyopathies; Female; Huma | 2012 |